Crossbow Therapeutics
Crossbow Therapeutics develops antibody therapies for cancer.
$77MSeries B
Role not disclosedActivity from announced rounds
Crossbow Therapeutics develops antibody therapies for cancer.
Develops inhaled therapies for severe respiratory diseases